Carbonic Anhydrase IX in Tumor Tissue and Plasma of Breast Cancer Patients: Reliable Biomarker of Hypoxia and Prognosis

Carbonic anhydrase IX (CA IX) is recognized as an excellent marker of hypoxia and an adverse prognostic factor in solid tumors, including breast cancer (BC). Clinical studies confirm that soluble CA IX (sCA IX), shed into body fluids, predicts the response to some therapeutics. However, CA IX is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezuchova, Ingeborg, Bartosova, Maria, Belvoncikova, Petra, Takacova, Martina, Zatovicova, Miriam, Jelenska, Lenka, Csaderova, Lucia, Meciarova, Iveta, Pohlodek, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002431/
https://www.ncbi.nlm.nih.gov/pubmed/36901756
http://dx.doi.org/10.3390/ijms24054325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002431/
https://www.ncbi.nlm.nih.gov/pubmed/36901756
http://dx.doi.org/10.3390/ijms24054325

Ejemplares similares